Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Other financing activities (2018 - 2024)

Health Catalyst's Other financing activities history spans 3 years, with the latest figure at -$848000.0 for Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to -$848000.0; the TTM value through Dec 2025 reached -$848000.0, changed 0.0%, while the annual FY2024 figure was $2.2 million, N/A changed from the prior year.
  • Other financing activities reached -$848000.0 in Q4 2024 per HCAT's latest filing, down from $203000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of -$848000.0 in Q4 2024 to a low of -$848000.0 in Q4 2024.